CC
LONA

Commodore Capital’s LeonaBio Inc LONA Stock Holding History

Commodore Capital’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Hold
464,398
– – 0.25% 32
2026
Q1 		$4.77M Hold
464,398
– – 0.28% 35
2025
Q4 		$3.52M Buy
+464,398
New +$2.13M 0.23% 32

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
SSC
Spruce Street Capital New York $510M AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Commodore Capital's LONA Position: Q2 2026 in Review

Commodore Capital held its LeonaBio Inc (LONA) position steady in Q2 2026 at 464,398 shares worth $4.27M. The position accounts for 0.25% of the portfolio, ranked #32.

Commodore Capital first reported a position in LONA in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.77M in Q1 2026. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • Commodore Capital held 464,398 shares of LeonaBio Inc worth $4.27M as of Q2 2026.
  • Commodore Capital left its LeonaBio Inc share count unchanged in Q2 2026.
  • LeonaBio Inc made up 0.25% of Commodore Capital's portfolio in Q2 2026, its #32 holding.
  • Commodore Capital first reported a position in LeonaBio Inc in Q4 2025 and has held it in 3 quarters since.
  • Commodore Capital's LeonaBio Inc position peaked at $4.77M in Q1 2026.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on Commodore Capital's 13F filing for Q2 2026, filed 14 Aug 2026.